sunitinib accord
accord healthcare s.l.u. - szunitinibbel - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - daganatellenes szerek - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib-azr 37,5 mg kemény kapszula
azr kft. - szunitinibbel -
sunitinib pharmascience 37,5 mg kemény kapszula
pharmascience international ltd. - szunitinibbel -
sunitinib msn 37,5 mg kemény kapszula
msn labs europe limited - szunitinibbel -
sunitinib teva 37,5 mg kemény kapszula
teva b.v. - szunitinibbel -
szunitinib mylan 37,5 mg kemény kapszula
mylan ireland ltd. - szunitinibbel -
sunitinib teva 25 mg kemény kapszula
teva b.v. - szunitinibbel -
sunitinib-azr 12,5 mg kemény kapszula
hcm pharma kft. - szunitinibbel -
sunitinib-azr 25 mg kemény kapszula
hcm pharma kft. - szunitinibbel -
sunitinib-azr 50 mg kemény kapszula
hcm pharma kft. - szunitinibbel -